Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs Upper Gastrointestinal Events Associated With Rofecoxib in a Colorectal Adenoma Chemoprevention Trial A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With Osteoarthritis A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia 52-Week Results From... Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and g... A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduo... A 52-week placebo-controlled trial of evolocumab in hyperlipidemia Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational... Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patie...
